feed,title,long_url,short_url
Benzinga,Hollister Biosciences Inc. Provides Update on Q4 2020 Performance Including CDN $14.93 Million in Revenue With an Estimated CDN $5.53 Million in EBITDA a YoY Revenue Increase of 3215% from Q4 2019,https://www.benzinga.com/pressreleases/21/01/n19071301/hollister-biosciences-inc-provides-update-on-q4-2020-performance-including-cdn-14-93-million-in-re,https://j.mp/35iRTXG
Benzinga,Hollister Biosciences Inc. Provides Update on Q4 2020 Performance Including CDN $14.93 Million in Revenue With an Estimated CDN $5.53 Million in EBITDA a YoY Revenue Increase of 3215% from Q4 2019,https://www.benzinga.com/pressreleases/21/01/n19071300/hollister-biosciences-inc-provides-update-on-q4-2020-performance-including-cdn-14-93-million-in-re,https://j.mp/38p1FK3
